SARGRAMOSTIM

SARGRAMOSTIM was reported 1730 times

SARGRAMOSTIM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SPONDYLOPATHY TRAUMATIC 2 0.2500
1 ALLERGENIC DESENSITISATION PROCEDURE 1 0.2000
2 ALVEOLAR AERATION EXCESSIVE 1 0.1250
3 ADRENAL CALCIFICATION 1 0.0588
4 DEVICE RELATED BACTERAEMIA 17 0.0548
5 BLOOD THROMBOPLASTIN DECREASED 1 0.0417
6 MUCOSAL MEMBRANE HYPERPLASIA 2 0.0364
7 NEUROBLASTOMA RECURRENT 7 0.0345
8 COELIAC ARTERY STENOSIS 3 0.0330
9 BRONCHOALVEOLAR LAVAGE 2 0.0328
10 URINE OUTPUT 2 0.0312
11 BENIGN OESOPHAGEAL NEOPLASM 1 0.0286
12 AV DISSOCIATION 1 0.0192
13 BLAST CELLS 1 0.0192
14 BLAST CELL PROLIFERATION 1 0.0175
15 NEUROBLASTOMA 6 0.0157
16 BLADDER NECROSIS 1 0.0156
17 ANAPLASTIC LYMPHOMA KINASE GENE MUTATION 1 0.0152
18 EPENDYMOMA 2 0.0138
19 BLADDER DIVERTICULUM 2 0.0127
20 BREAST PROSTHESIS REMOVAL 1 0.0123
21 NASAL ODOUR 2 0.0120
22 BENIGN GASTRIC NEOPLASM 1 0.0119
23 BIOPSY BREAST ABNORMAL 1 0.0105
24 HAEMANGIOMA OF BONE 2 0.0105
25 CSF GLUCOSE INCREASED 1 0.0104
26 TRANSAMINASES ABNORMAL 6 0.0103
27 BIOPSY LYMPH GLAND 1 0.0102
28 GASTRODUODENITIS 2 0.0098
29 SALIVARY GLAND PAIN 2 0.0093
30 ATROPHIC GLOSSITIS 1 0.0092
31 BREATH SOUNDS ABSENT 1 0.0091
32 ABDOMINAL REBOUND TENDERNESS 1 0.0089
33 BLADDER DISTENSION 1 0.0079
34 ADMINISTRATION SITE RASH 1 0.0078
35 DISSEMINATED MUCORMYCOSIS 3 0.0076
36 ALLERGIC RESPIRATORY DISEASE 1 0.0072
37 GENE MUTATION IDENTIFICATION TEST POSITIVE 3 0.0071
38 BONE SCAN ABNORMAL 3 0.0071
39 ALVEOLAR PROTEINOSIS 4 0.0068
40 BILIARY SEPSIS 3 0.0065
41 CENTRAL NERVOUS SYSTEM NEOPLASM 1 0.0062
42 ADNEXA UTERI CYST 1 0.0062
43 ORAL DISCHARGE 2 0.0055
44 CENTRAL LINE INFECTION 2 0.0054
45 BAND NEUTROPHIL COUNT INCREASED 1 0.0051
46 OBSTRUCTIVE UROPATHY 2 0.0050
47 RED BLOOD CELL TRANSFUSION 2 0.0049
48 CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION 1 0.0048
49 MELANOMA RECURRENT 2 0.0048
50 GLIOSIS 2 0.0047
51 ASPARTATE AMINOTRANSFERASE ABNORMAL 7 0.0046
52 TRANSFUSION REACTION 4 0.0046
53 CAECITIS 2 0.0044
54 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 2 0.0044
55 DYSPHASIA 2 0.0043
56 BREATHING-RELATED SLEEP DISORDER 1 0.0042
57 BONE DEBRIDEMENT 2 0.0041
58 METASTATIC MALIGNANT MELANOMA 9 0.0039
59 OBSTRUCTION GASTRIC 5 0.0039
60 B-CELL APLASIA 1 0.0039
61 CULTURE WOUND POSITIVE 1 0.0038
62 COLONIC OBSTRUCTION 1 0.0038
63 BACTEROIDES INFECTION 1 0.0038
64 OSTEOSCLEROSIS 6 0.0038
65 NEUTROPHIL PERCENTAGE DECREASED 2 0.0038
66 COAGULATION FACTOR DECREASED 1 0.0037
67 VERTEBRAL FORAMINAL STENOSIS 3 0.0036
68 CHOLESTEATOMA 1 0.0036
69 ENCEPHALOMALACIA 2 0.0036
70 APNOEIC ATTACK 2 0.0035
71 THYROXINE FREE DECREASED 2 0.0035
72 ADMINISTRATION SITE ERYTHEMA 1 0.0035
73 SICK SINUS SYNDROME 4 0.0035
74 CAPILLARY LEAK SYNDROME 7 0.0034
75 PRIMARY SEQUESTRUM 3 0.0033
76 RETINAL ISCHAEMIA 2 0.0033
77 ASPERGILLUS TEST POSITIVE 1 0.0032
78 VITAMIN D INCREASED 2 0.0032
79 OSTEOMYELITIS CHRONIC 2 0.0032
80 ADMINISTRATION SITE SWELLING 1 0.0031
81 PAROTID GLAND ENLARGEMENT 2 0.0031
82 MARROW HYPERPLASIA 2 0.0029
83 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE EXACERBATED 1 0.0029
84 FUSARIUM INFECTION 2 0.0029
85 ALANINE AMINOTRANSFERASE ABNORMAL 6 0.0028
86 VENOUS OCCLUSION 5 0.0027
87 ATROPHIC VULVOVAGINITIS 2 0.0027
88 PUPILLARY REFLEX IMPAIRED 5 0.0027
89 PARATHYROID TUMOUR BENIGN 2 0.0027
90 HEART SOUNDS ABNORMAL 2 0.0027
91 BREAST RECONSTRUCTION 1 0.0027
92 PNEUMONIA CYTOMEGALOVIRAL 5 0.0026
93 ADRENAL GLAND CANCER 1 0.0026
94 GLOMERULONEPHRITIS MEMBRANOUS 3 0.0026
95 BRAIN COMPRESSION 1 0.0025
96 GINGIVAL INFECTION 2 0.0025
97 HEAT EXHAUSTION 2 0.0025
98 DEATH OF RELATIVE 1 0.0025
99 CARDIAC VENTRICULAR DISORDER 1 0.0024
100 SEPTIC EMBOLUS 2 0.0024
101 CAROTID ARTERY DISSECTION 1 0.0023
102 ASPERGILLOSIS 3 0.0023
103 KYPHOSIS 4 0.0023
104 PROTEIN URINE 2 0.0022
105 CERUMEN IMPACTION 2 0.0022
106 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 1 0.0022
107 ENTEROCOLITIS INFECTIOUS 2 0.0022
108 TEMPORAL ARTERITIS 2 0.0022
109 CHLOASMA 1 0.0022
110 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 1 0.0021
111 CULTURE URINE POSITIVE 3 0.0021
112 CENTRAL VENOUS CATHETER REMOVAL 1 0.0021
113 ACTINOMYCOSIS 2 0.0021
114 MASTOIDITIS 2 0.0020
115 INJECTION SITE INFLAMMATION 10 0.0020
116 CSF TEST ABNORMAL 1 0.0020
117 AORTIC VALVE CALCIFICATION 1 0.0019
118 NEUTROPENIC COLITIS 4 0.0019
119 LIVEDO RETICULARIS 4 0.0019
120 HYPOPERFUSION 2 0.0019
121 CHRONIC MYELOID LEUKAEMIA RECURRENT 1 0.0018
122 BLOOD PH INCREASED 1 0.0018
123 EPSTEIN-BARR VIRAEMIA 2 0.0018
124 HYPOALBUMINAEMIA 14 0.0018
125 BRAIN SCAN ABNORMAL 1 0.0018
126 PULMONARY GRANULOMA 2 0.0018
127 CARBON DIOXIDE DECREASED 2 0.0017
128 TREATMENT DELAYED 3 0.0017
129 AORTIC CALCIFICATION 1 0.0017
130 BLOOD OESTROGEN INCREASED 1 0.0017
131 DEVICE RELATED INFECTION 26 0.0017
132 BILIARY TRACT INFECTION 1 0.0016
133 STEM CELL TRANSPLANT 4 0.0016
134 VENOOCCLUSIVE DISEASE 4 0.0016
135 BACILLUS INFECTION 1 0.0016
136 ENDOCRINE DISORDER 2 0.0016
137 PLATELET TRANSFUSION 2 0.0016
138 LOOSE TOOTH 5 0.0016
139 IMMUNE RECONSTITUTION SYNDROME 2 0.0015
140 HYPOPHYSITIS 3 0.0015
141 RHONCHI 2 0.0014
142 DILATATION VENTRICULAR 3 0.0014
143 INTESTINAL FISTULA 2 0.0014
144 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
145 BONE LESION 5 0.0014
146 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
147 CLONIC CONVULSION 1 0.0014
148 B-CELL TYPE ACUTE LEUKAEMIA 1 0.0014
149 LARGE INTESTINAL HAEMORRHAGE 3 0.0013
150 CHRONIC SINUSITIS 5 0.0013
151 NORMOCHROMIC NORMOCYTIC ANAEMIA 4 0.0013
152 BASOPHIL COUNT INCREASED 1 0.0013
153 ACUTE GRAFT VERSUS HOST DISEASE 6 0.0013
154 ASPIRATION PLEURAL CAVITY 1 0.0013
155 BILIRUBIN CONJUGATED INCREASED 3 0.0013
156 CRITICAL ILLNESS 1 0.0013
157 ASEPTIC NECROSIS BONE 1 0.0013
158 IDIOPATHIC THROMBOCYTOPENIC PURPURA 2 0.0013
159 URINARY HESITATION 3 0.0013
160 PNEUMONIA LEGIONELLA 2 0.0012
161 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 1 0.0012
162 BACTERIAL SEPSIS 4 0.0012
163 ANAL ULCER 1 0.0012
164 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
165 SMALL INTESTINAL OBSTRUCTION 15 0.0012
166 BALANOPOSTHITIS 1 0.0012
167 SPLENIC RUPTURE 2 0.0012
168 DEAFNESS NEUROSENSORY 4 0.0012
169 COLLAPSE OF LUNG 1 0.0012
170 CSF PROTEIN INCREASED 1 0.0012
171 EMBOLISM 10 0.0012
172 VENTRICULAR HYPERTROPHY 3 0.0012
173 OSTEITIS 3 0.0012
174 CEREBRAL VENOUS SINUS THROMBOSIS 1 0.0012
175 CEREBELLAR INFARCTION 2 0.0012
176 PROSTATIC SPECIFIC ANTIGEN INCREASED 16 0.0012
177 BLOOD PROLACTIN ABNORMAL 1 0.0012
178 ADRENAL INSUFFICIENCY 14 0.0012
179 SPLENIC INFARCTION 2 0.0011
180 AXONAL NEUROPATHY 1 0.0011
181 GASTROINTESTINAL OEDEMA 2 0.0011
182 CANDIDA SEPSIS 1 0.0011
183 LIVER TRANSPLANT REJECTION 2 0.0011
184 ANAEMIA OF CHRONIC DISEASE 1 0.0011
185 PNEUMOMEDIASTINUM 2 0.0011
186 CONDUCTION DISORDER 2 0.0011
187 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0011
188 GRANULOCYTE COUNT DECREASED 2 0.0011
189 LYMPH NODE PAIN 2 0.0011
190 HYPERTENSIVE HEART DISEASE 2 0.0011
191 FACE INJURY 4 0.0011
192 PULSE ABSENT 5 0.0011
193 LIPASE INCREASED 8 0.0010
194 GINGIVAL RECESSION 2 0.0010
195 ENTEROCOLITIS 6 0.0010
196 ADENOVIRUS INFECTION 3 0.0010
197 BONE SWELLING 1 0.0010
198 PURULENCE 2 0.0010
199 BONE MARROW DEPRESSION 1 0.0010
200 HYPOGEUSIA 2 0.0010
201 OCCULT BLOOD POSITIVE 2 0.0010
202 COLON ADENOMA 1 0.0010
203 HYPERVOLAEMIA 5 0.0010
204 ANORECTAL DISORDER 2 0.0010
205 HYPERCAPNIA 3 0.0010
206 DIVERTICULUM 7 0.0010
207 HYPERPARATHYROIDISM 2 0.0010
208 ALVEOLITIS ALLERGIC 1 0.0010
209 ABSCESS JAW 1 0.0010
210 NON-CARDIAC CHEST PAIN 3 0.0009
211 CEREBRAL ARTERY OCCLUSION 1 0.0009
212 ACUTE MYELOID LEUKAEMIA RECURRENT 2 0.0009
213 JAW FRACTURE 2 0.0009
214 LYMPHOCYTE COUNT INCREASED 3 0.0009
215 NOSOCOMIAL INFECTION 2 0.0009
216 PROSTATE CANCER METASTATIC 3 0.0009
217 PSEUDOMEMBRANOUS COLITIS 2 0.0009
218 METASTASES TO SPINE 3 0.0009
219 ADENOCARCINOMA 2 0.0009
220 CATHETER RELATED COMPLICATION 1 0.0009
221 WOUND DEHISCENCE 3 0.0009
222 CLOSTRIDIAL INFECTION 3 0.0009
223 CYTOGENETIC ABNORMALITY 1 0.0009
224 HEPATIC CYST 3 0.0009
225 ABDOMINAL HERNIA 4 0.0009
226 VISUAL DISTURBANCE 5 0.0009
227 LARGE INTESTINE PERFORATION 6 0.0009
228 DEVICE OCCLUSION 12 0.0009
229 HYPOXIA 30 0.0009
230 ESCHERICHIA BACTERAEMIA 2 0.0008
231 BRONCHOSPASM 12 0.0008
232 LACUNAR INFARCTION 2 0.0008
233 GRAFT VERSUS HOST DISEASE 6 0.0008
234 CHRONIC GRAFT VERSUS HOST DISEASE 3 0.0008
235 AUTOIMMUNE DISORDER 8 0.0008
236 DERMAL CYST 2 0.0008
237 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
238 CUTANEOUS T-CELL LYMPHOMA 1 0.0008
239 METASTASES TO BONE 13 0.0008
240 FEBRILE NEUTROPENIA 52 0.0008
241 CANCER PAIN 2 0.0008
242 GINGIVAL DISORDER 3 0.0008
243 ADENOCARCINOMA PANCREAS 1 0.0008
244 CEREBRAL ISCHAEMIA 4 0.0008
245 AORTIC ARTERIOSCLEROSIS 2 0.0008
246 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 2 0.0008
247 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
248 LIPOMA 2 0.0008
249 MYELODYSPLASTIC SYNDROME 11 0.0008
250 ANIMAL BITE 2 0.0007
251 CANDIDIASIS 3 0.0007
252 LARYNGOSPASM 2 0.0007
253 JAW DISORDER 4 0.0007
254 ABSCESS ORAL 1 0.0007
255 PLEURITIC PAIN 2 0.0007
256 SERUM SICKNESS 2 0.0007
257 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0007
258 IMMUNE THROMBOCYTOPENIC PURPURA 2 0.0007
259 LUNG NEOPLASM 3 0.0007
260 METASTATIC NEOPLASM 3 0.0007
261 HEPATIC LESION 3 0.0007
262 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
263 BLOOD PARATHYROID HORMONE INCREASED 2 0.0007
264 MELANOCYTIC NAEVUS 3 0.0007
265 SPLENOMEGALY 8 0.0007
266 LYMPHOPROLIFERATIVE DISORDER 2 0.0007
267 STRIDOR 2 0.0007
268 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
269 HISTIOCYTOSIS HAEMATOPHAGIC 2 0.0007
270 CHOLECYSTITIS 8 0.0007
271 METABOLIC ENCEPHALOPATHY 2 0.0007
272 BONE PAIN 39 0.0007
273 VASCULAR DEVICE INFECTION 3 0.0007
274 BLOOD PRESSURE IMMEASURABLE 1 0.0007
275 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
276 WHITE BLOOD CELL COUNT INCREASED 25 0.0007
277 OLIGURIA 4 0.0006
278 INJECTION SITE HYPERSENSITIVITY 2 0.0006
279 SINUS TACHYCARDIA 9 0.0006
280 ENTERITIS 4 0.0006
281 FAECAL INCONTINENCE 3 0.0006
282 COLON CANCER METASTATIC 1 0.0006
283 ACUTE LEUKAEMIA 1 0.0006
284 BRADYARRHYTHMIA 1 0.0006
285 BREATH SOUNDS ABNORMAL 3 0.0006
286 HYPOKALAEMIA 28 0.0006
287 COLONIC POLYP 1 0.0006
288 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 2 0.0006
289 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
290 POTENTIATING DRUG INTERACTION 2 0.0006
291 OSTEOPENIA 9 0.0006
292 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
293 SUPRAVENTRICULAR EXTRASYSTOLES 2 0.0006
294 DEAFNESS BILATERAL 1 0.0006
295 TACHYPNOEA 8 0.0006
296 BLOOD PH DECREASED 1 0.0006
297 BLOOD AMYLASE INCREASED 1 0.0006
298 DIFFICULTY IN WALKING 2 0.0006
299 ACUTE SINUSITIS 1 0.0006
300 BLOOD CHLORIDE INCREASED 1 0.0006
301 BLOOD CREATININE ABNORMAL 2 0.0006
302 ACUTE MYELOID LEUKAEMIA 9 0.0006
303 MENTAL STATUS CHANGES 16 0.0006
304 BREAST DISCHARGE 1 0.0006
305 SPINAL OSTEOARTHRITIS 5 0.0006
306 LUNG INFILTRATION 5 0.0006
307 TOOTH EXTRACTION 7 0.0006
308 COMPRESSION FRACTURE 3 0.0006
309 COLITIS 21 0.0006
310 HYPOTENSION 111 0.0006
311 TOOTHACHE 10 0.0006
312 INJECTION SITE REACTION 38 0.0006
313 OSTEOMYELITIS 10 0.0006
314 METASTASES TO CENTRAL NERVOUS SYSTEM 7 0.0005
315 ALCOHOL USE 2 0.0005
316 CYTOMEGALOVIRUS INFECTION 9 0.0005
317 SYNCOPE 54 0.0005
318 NECROSIS 3 0.0005
319 HYPOCALCAEMIA 10 0.0005
320 BONE MARROW TRANSPLANT 1 0.0005
321 BILE DUCT OBSTRUCTION 1 0.0005
322 BLOOD URIC ACID INCREASED 3 0.0005
323 ATELECTASIS 5 0.0005
324 EYELID OEDEMA 6 0.0005
325 EJECTION FRACTION DECREASED 8 0.0005
326 EOSINOPHILIA 9 0.0005
327 THERAPY PARTIAL RESPONDER 8 0.0005
328 HYPOVOLAEMIA 3 0.0005
329 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
330 BLOOD ALBUMIN DECREASED 4 0.0005
331 RENAL CYST 4 0.0005
332 TRICUSPID VALVE INCOMPETENCE 4 0.0005
333 CEREBRAL ATROPHY 2 0.0005
334 ATRIAL FLUTTER 4 0.0005
335 NO THERAPEUTIC RESPONSE 6 0.0005
336 TOOTH ABSCESS 5 0.0005
337 GOITRE 2 0.0005
338 HYPERURICAEMIA 2 0.0005
339 CHILLS 57 0.0005
340 HYPERCALCAEMIA 6 0.0005
341 SCOLIOSIS 3 0.0005
342 ILEUS 6 0.0005
343 SECOND PRIMARY MALIGNANCY 4 0.0005
344 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
345 BLOOD UREA INCREASED 8 0.0005
346 ASCITES 14 0.0005
347 ATRIAL TACHYCARDIA 1 0.0005
348 SUDDEN DEATH 5 0.0005
349 ANAEMIA MACROCYTIC 1 0.0005
350 CATHETER SITE ERYTHEMA 1 0.0005
351 BLOOD TESTOSTERONE INCREASED 1 0.0005
352 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
353 PYREXIA 158 0.0005
354 ONYCHOMYCOSIS 2 0.0005
355 SARS-COV-2 TEST POSITIVE 6 0.0005
356 CLOSTRIDIUM TEST POSITIVE 1 0.0005
357 ABDOMINAL ABSCESS 2 0.0005
358 APPETITE DISORDER 3 0.0005
359 PRESYNCOPE 11 0.0005
360 BACTERIAL TEST POSITIVE 1 0.0004
361 MALNUTRITION 5 0.0004
362 ORAL PAIN 10 0.0004
363 HAEMOLYTIC ANAEMIA 4 0.0004
364 METASTASES TO LYMPH NODES 3 0.0004
365 BONE MARROW FAILURE 9 0.0004
366 SUSPECTED OFF LABEL USE 2 0.0004
367 PRODUCT LABEL ISSUE 3 0.0004
368 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
369 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
370 BONE DISORDER 8 0.0004
371 CROHN'S DISEASE 3 0.0004
372 RESPIRATION ABNORMAL 3 0.0004
373 ISCHAEMIA 2 0.0004
374 PERICARDIAL EFFUSION 10 0.0004
375 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
376 LOCALISED OEDEMA 2 0.0004
377 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
378 DEHYDRATION 57 0.0004
379 OXYGEN SATURATION DECREASED 24 0.0004
380 CHOLELITHIASIS 14 0.0004
381 LYMPHADENOPATHY 15 0.0004
382 MUCOSAL INFLAMMATION 11 0.0004
383 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
384 PULMONARY FIBROSIS 8 0.0004
385 VULVOVAGINAL PAIN 2 0.0004
386 ENTEROCOCCAL INFECTION 2 0.0004
387 SINUS BRADYCARDIA 4 0.0004
388 NOCTURIA 5 0.0004
389 THROMBOTIC MICROANGIOPATHY 4 0.0004
390 HEPATOMEGALY 4 0.0004
391 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
392 VENOOCCLUSIVE LIVER DISEASE 2 0.0004
393 OSTEONECROSIS OF JAW 10 0.0004
394 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
395 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
396 IMMUNODEFICIENCY 6 0.0004
397 RENAL FAILURE ACUTE 17 0.0004
398 CATHETER SITE HAEMORRHAGE 1 0.0004
399 CORONARY ARTERY STENOSIS 2 0.0004
400 EMPHYSEMA 4 0.0004
401 PRODUCT SOLUBILITY ABNORMAL 2 0.0004
402 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 2 0.0004
403 INJECTION SITE IRRITATION 5 0.0004
404 NEUTROPHIL COUNT INCREASED 4 0.0004
405 MYDRIASIS 5 0.0004
406 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
407 UNRESPONSIVE TO STIMULI 10 0.0004
408 HYPERBILIRUBINAEMIA 4 0.0004
409 INJECTION SITE INDURATION 5 0.0004
410 CATHETER SITE PAIN 1 0.0004
411 THROMBOCYTOPENIA 43 0.0004
412 PULMONARY HAEMORRHAGE 3 0.0004
413 PLATELET COUNT INCREASED 5 0.0004
414 TACHYCARDIA 34 0.0004
415 PLEURAL EFFUSION 23 0.0004
416 GINGIVAL PAIN 3 0.0004
417 PANCYTOPENIA 21 0.0004
418 ANAL ABSCESS 2 0.0004
419 PALLOR 10 0.0004
420 CLONUS 1 0.0004
421 ESCHERICHIA INFECTION 3 0.0004
422 ACUTE RESPIRATORY FAILURE 7 0.0004
423 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
424 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
425 HYPONATRAEMIA 20 0.0004
426 DEEP VEIN THROMBOSIS 23 0.0004
427 SINUS DISORDER 7 0.0004
428 HAEMATOCRIT DECREASED 7 0.0004
429 GENERALISED ERYTHEMA 2 0.0004
430 BLOOD MAGNESIUM DECREASED 3 0.0003
431 RALES 2 0.0003
432 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
433 LEUKOPENIA 17 0.0003
434 LYMPHOCYTE COUNT DECREASED 6 0.0003
435 NEUTROPENIA 46 0.0003
436 SINUS HEADACHE 2 0.0003
437 CREPITATIONS 1 0.0003
438 BRAIN HERNIATION 1 0.0003
439 HAEMORRHAGE INTRACRANIAL 5 0.0003
440 PROTHROMBIN TIME PROLONGED 2 0.0003
441 CENTRAL VENOUS CATHETERISATION 1 0.0003
442 LEUKOCYTOSIS 6 0.0003
443 BONE MARROW DISORDER 1 0.0003
444 DISEASE PROGRESSION 39 0.0003
445 DERMATITIS ACNEIFORM 2 0.0003
446 RETINAL DETACHMENT 3 0.0003
447 RESPIRATORY DISTRESS 9 0.0003
448 CARDIOMEGALY 4 0.0003
449 GRAND MAL CONVULSION 3 0.0003
450 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
451 GENERALISED OEDEMA 4 0.0003
452 CHOLANGITIS 2 0.0003
453 NEPHROPATHY 3 0.0003
454 FLANK PAIN 3 0.0003
455 BLOOD CREATININE DECREASED 1 0.0003
456 LACERATION 3 0.0003
457 BREAST CANCER RECURRENT 1 0.0003
458 BLADDER PAIN 1 0.0003
459 PROCTALGIA 2 0.0003
460 HYPERCHOLESTEROLAEMIA 3 0.0003
461 HYPERHIDROSIS 40 0.0003
462 ANOREXIA 4 0.0003
463 INCOHERENT 2 0.0003
464 RASH GENERALISED 8 0.0003
465 HIATUS HERNIA 4 0.0003
466 HERPES SIMPLEX 2 0.0003
467 ANGINA UNSTABLE 2 0.0003
468 BLOOD CREATININE INCREASED 20 0.0003
469 DEAFNESS 8 0.0003
470 OSTEONECROSIS 10 0.0003
471 PULMONARY CONGESTION 4 0.0003
472 DEPRESSED LEVEL OF CONSCIOUSNESS 12 0.0003
473 MENINGITIS 2 0.0003
474 MALIGNANT MELANOMA 4 0.0003
475 BREAST MASS 2 0.0003
476 BK VIRUS INFECTION 1 0.0003
477 HEMIPARESIS 5 0.0003
478 BRONCHOPNEUMONIA 1 0.0003
479 NEPHROTIC SYNDROME 2 0.0003
480 APLASIA PURE RED CELL 1 0.0003
481 MUSCULOSKELETAL DISCOMFORT 5 0.0003
482 MULTI-ORGAN FAILURE 5 0.0003
483 HYPERTRANSAMINASAEMIA 2 0.0003
484 AORTIC STENOSIS 1 0.0003
485 CAROTID ARTERY STENOSIS 1 0.0003
486 DUODENAL ULCER 2 0.0003
487 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
488 PULMONARY TOXICITY 2 0.0003
489 BONE EROSION 1 0.0003
490 PAIN IN JAW 8 0.0003
491 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
492 NEUTROPENIC SEPSIS 2 0.0003
493 HYPERTHYROIDISM 4 0.0003
494 OESOPHAGITIS 3 0.0003
495 HYPERGLYCAEMIA 10 0.0003
496 RESPIRATORY FAILURE 20 0.0003
497 CUTANEOUS VASCULITIS 1 0.0003
498 AMYLASE INCREASED 1 0.0003
499 HYPOPHOSPHATAEMIA 2 0.0003
500 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
501 CEREBRAL DISORDER 2 0.0003
502 VENTRICULAR FIBRILLATION 3 0.0003
503 TRANSAMINASES INCREASED 6 0.0003
504 HYDRONEPHROSIS 2 0.0003
505 FISTULA 3 0.0003
506 MITRAL VALVE INCOMPETENCE 3 0.0003
507 CHOLECYSTECTOMY 3 0.0003
508 OEDEMA PERIPHERAL 32 0.0003
509 HAEMODYNAMIC INSTABILITY 2 0.0003
510 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
511 ACIDOSIS 2 0.0003
512 BOWEL MOVEMENT IRREGULARITY 2 0.0003
513 CLAVICLE FRACTURE 1 0.0003
514 SHOCK 6 0.0003
515 RENAL FAILURE CHRONIC 2 0.0003
516 METASTASES TO LUNG 3 0.0003
517 HAEMOLYSIS 2 0.0003
518 VASCULITIS 3 0.0003
519 HYPERKALAEMIA 9 0.0003
520 CARDIOPULMONARY FAILURE 1 0.0003
521 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
522 CYANOSIS 4 0.0003
523 ANAPHYLACTIC REACTION 14 0.0003
524 BACTERAEMIA 3 0.0003
525 PNEUMOTHORAX 4 0.0003
526 HYPERLIPIDAEMIA 3 0.0003
527 SEPSIS 28 0.0003
528 HAEMOPTYSIS 7 0.0003
529 CYTOKINE RELEASE SYNDROME 5 0.0002
530 WHITE BLOOD CELL COUNT DECREASED 27 0.0002
531 ATRIAL FIBRILLATION 24 0.0002
532 FLUSHING 25 0.0002
533 CEREBRAL INFARCTION 6 0.0002
534 CONVULSION 14 0.0002
535 HICCUPS 2 0.0002
536 ANAPHYLACTOID REACTION 1 0.0002
537 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
538 HAIR DISORDER 2 0.0002
539 HOSPITALISATION 37 0.0002
540 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
541 MOUTH ULCERATION 5 0.0002
542 AORTIC VALVE INCOMPETENCE 1 0.0002
543 CARDIAC FAILURE CHRONIC 1 0.0002
544 FACIAL PARALYSIS 2 0.0002
545 MALIGNANT NEOPLASM PROGRESSION 24 0.0002
546 LOSS OF CONSCIOUSNESS 30 0.0002
547 INJECTION SITE ERYTHEMA 29 0.0002
548 RECTAL HAEMORRHAGE 10 0.0002
549 SKIN HYPERPIGMENTATION 2 0.0002
550 HEPATIC FAILURE 7 0.0002
551 PSYCHOLOGICAL TRAUMA 2 0.0002
552 MUSCLE STRAIN 2 0.0002
553 ORTHOSTATIC HYPOTENSION 4 0.0002
554 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
555 BEDRIDDEN 3 0.0002
556 INJECTION SITE RASH 7 0.0002
557 BLOOD CALCIUM INCREASED 2 0.0002
558 METASTASES TO LIVER 4 0.0002
559 TOOTH INFECTION 3 0.0002
560 TUMOUR LYSIS SYNDROME 2 0.0002
561 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
562 BLOOD CREATINE INCREASED 1 0.0002
563 RASH MACULO-PAPULAR 5 0.0002
564 NEOPLASM MALIGNANT 15 0.0002
565 CARDIOTOXICITY 2 0.0002
566 INJECTION SITE PRURITUS 15 0.0002
567 JOINT RANGE OF MOTION DECREASED 3 0.0002
568 MYOSITIS 2 0.0002
569 ANAL INCONTINENCE 2 0.0002
570 BLOOD BILIRUBIN INCREASED 6 0.0002
571 SINUS CONGESTION 3 0.0002
572 THROAT TIGHTNESS 6 0.0002
573 CHEST PAIN 41 0.0002
574 ANAEMIA 42 0.0002
575 EXOSTOSIS 2 0.0002
576 METABOLIC ACIDOSIS 7 0.0002
577 CELLULITIS 11 0.0002
578 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
579 NIGHT SWEATS 7 0.0002
580 IRON DEFICIENCY ANAEMIA 2 0.0002
581 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
582 PLATELET COUNT DECREASED 23 0.0002
583 HEPATIC STEATOSIS 4 0.0002
584 BACTERIAL INFECTION 4 0.0002
585 IMPAIRED HEALING 7 0.0002
586 PHOTOPHOBIA 4 0.0002
587 ARTERIOSCLEROSIS 2 0.0002
588 SQUAMOUS CELL CARCINOMA 2 0.0002
589 SEASONAL ALLERGY 3 0.0002
590 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
591 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
592 PRODUCT PACKAGING ISSUE 2 0.0002
593 GASTRIC ULCER 4 0.0002
594 CARDIAC TAMPONADE 1 0.0002
595 CARDIOGENIC SHOCK 3 0.0002
596 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
597 INJECTION SITE SWELLING 16 0.0002
598 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
599 ERUCTATION 4 0.0002
600 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
601 ABDOMINAL PAIN 48 0.0002
602 LIVER FUNCTION TEST ABNORMAL 6 0.0002
603 FLUID OVERLOAD 3 0.0002
604 INFLAMMATORY BOWEL DISEASE 2 0.0002
605 HAEMATURIA 7 0.0002
606 LUNG DISORDER 10 0.0002
607 INJECTION SITE URTICARIA 5 0.0002
608 CARDIOMYOPATHY 3 0.0002
609 URTICARIA 34 0.0002
610 ABASIA 5 0.0002
611 DECREASED APPETITE 47 0.0002
612 DISABILITY 4 0.0002
613 LIGAMENT SPRAIN 2 0.0002
614 ABDOMINAL TENDERNESS 1 0.0002
615 PULMONARY OEDEMA 9 0.0002
616 EPISTAXIS 15 0.0002
617 OVARIAN CYST 2 0.0002
618 HYPOAESTHESIA ORAL 3 0.0002
619 APHASIA 6 0.0002
620 FULL BLOOD COUNT DECREASED 4 0.0002
621 BODY TEMPERATURE INCREASED 4 0.0002
622 CHEST DISCOMFORT 20 0.0002
623 RIB FRACTURE 4 0.0002
624 DYSPNOEA 110 0.0002
625 MUSCULOSKELETAL CHEST PAIN 3 0.0002
626 POOR VENOUS ACCESS 2 0.0002
627 VENTRICULAR EXTRASYSTOLES 2 0.0002
628 BASAL CELL CARCINOMA 3 0.0002
629 PULMONARY HYPERTENSION 4 0.0002
630 PETECHIAE 2 0.0002
631 ANHEDONIA 5 0.0002
632 GASTRITIS 5 0.0002
633 PULMONARY EMBOLISM 18 0.0002
634 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
635 HYPOTHYROIDISM 6 0.0002
636 HYPOACUSIS 8 0.0002
637 OEDEMA 10 0.0002
638 PAIN 113 0.0002
639 BACK INJURY 2 0.0002
640 WOUND INFECTION 2 0.0002
641 MANIA 3 0.0002
642 INFLUENZA LIKE ILLNESS 15 0.0002
643 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 10 0.0002
644 GASTROINTESTINAL PAIN 2 0.0002
645 INJECTION SITE NODULE 2 0.0002
646 TOOTH FRACTURE 2 0.0002
647 CHOKING SENSATION 1 0.0002
648 DENTAL CARIES 2 0.0002
649 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
650 OFF LABEL USE 155 0.0002
651 VOMITING 83 0.0002
652 BACK PAIN 41 0.0002
653 MYOCARDIAL ISCHAEMIA 2 0.0002
654 ANGINA PECTORIS 5 0.0002
655 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
656 CONFUSIONAL STATE 28 0.0002
657 NEOPLASM PROGRESSION 6 0.0002
658 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
659 MADAROSIS 2 0.0002
660 BLINDNESS 7 0.0002
661 NEUTROPHIL COUNT DECREASED 7 0.0002
662 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
663 SWELLING 16 0.0002
664 DECREASED INTEREST 1 0.0002
665 CARDIAC ARREST 14 0.0002
666 NEUROPATHY PERIPHERAL 16 0.0002
667 OSTEOARTHRITIS 7 0.0002
668 RESTLESS LEGS SYNDROME 3 0.0002
669 DYSURIA 6 0.0002
670 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
671 NAUSEA 128 0.0002
672 CYST 2 0.0002
673 HAIR COLOUR CHANGES 2 0.0002
674 HYPERTENSION 34 0.0002
675 CONSTIPATION 35 0.0002
676 SWOLLEN TONGUE 5 0.0002
677 DYSPNOEA EXERTIONAL 6 0.0002
678 BLOOD SODIUM DECREASED 3 0.0002
679 UNEVALUABLE EVENT 12 0.0002
680 MUSCULAR WEAKNESS 18 0.0002
681 BRAIN OEDEMA 2 0.0002
682 SLEEP APNOEA SYNDROME 3 0.0002
683 CYSTITIS 5 0.0002
684 HEPATIC CYTOLYSIS 2 0.0002
685 ERECTILE DYSFUNCTION 4 0.0002
686 ANAPHYLACTIC SHOCK 4 0.0002
687 SKIN ULCER 4 0.0002
688 WEIGHT DECREASED 43 0.0002
689 HAEMORRHOIDS 3 0.0002
690 SWELLING FACE 10 0.0002
691 RESPIRATORY TRACT INFECTION 4 0.0002
692 ORAL CANDIDIASIS 2 0.0002
693 STAPHYLOCOCCAL INFECTION 5 0.0002
694 INFUSION RELATED REACTION 10 0.0002
695 HYPERSENSITIVITY 28 0.0002
696 BRADYCARDIA 8 0.0002
697 BLOOD PRESSURE DECREASED 10 0.0002
698 EYE HAEMORRHAGE 2 0.0001
699 COUGH 42 0.0001
700 HAIR TEXTURE ABNORMAL 2 0.0001
701 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
702 DRUG TOXICITY 2 0.0001
703 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
704 GINGIVAL BLEEDING 2 0.0001
705 RASH ERYTHEMATOUS 7 0.0001
706 TREATMENT NONCOMPLIANCE 8 0.0001
707 BLOOD TESTOSTERONE DECREASED 1 0.0001
708 HOT FLUSH 11 0.0001
709 INJECTION SITE WARMTH 3 0.0001
710 CORONARY ARTERY OCCLUSION 2 0.0001
711 INFECTION 21 0.0001
712 TOOTH LOSS 3 0.0001
713 HYPOMAGNESAEMIA 2 0.0001
714 CARDIO-RESPIRATORY ARREST 6 0.0001
715 MASS 2 0.0001
716 DEFAECATION URGENCY 1 0.0001
717 SKIN REACTION 2 0.0001
718 LYMPHOPENIA 2 0.0001
719 HEPATOCELLULAR INJURY 2 0.0001
720 RETCHING 3 0.0001
721 RED BLOOD CELL COUNT DECREASED 4 0.0001
722 LIVER FUNCTION TEST INCREASED 3 0.0001
723 LETHARGY 8 0.0001
724 ANOSMIA 2 0.0001
725 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
726 HYPOKINESIA 2 0.0001
727 CARDIAC FAILURE CONGESTIVE 11 0.0001
728 MYALGIA 23 0.0001
729 URINARY INCONTINENCE 4 0.0001
730 DIARRHOEA 87 0.0001
731 HEPATOTOXICITY 3 0.0001
732 EYE SWELLING 5 0.0001
733 MUSCULOSKELETAL PAIN 7 0.0001
734 PANCREATITIS ACUTE 3 0.0001
735 BONE LOSS 2 0.0001
736 BLOOD POTASSIUM DECREASED 4 0.0001
737 BREAST TENDERNESS 1 0.0001
738 BLOOD COUNT ABNORMAL 2 0.0001
739 STOMATITIS 8 0.0001
740 DRUG DISPENSING ERROR 2 0.0001
741 NEPHROLITHIASIS 6 0.0001
742 FEELING HOT 8 0.0001
743 MUSCLE TWITCHING 3 0.0001
744 TENDONITIS 2 0.0001
745 APNOEA 1 0.0001
746 BURNING SENSATION 9 0.0001
747 RENAL FAILURE 17 0.0001
748 AFFECTIVE DISORDER 1 0.0001
749 DIZZINESS 63 0.0001
750 ABSCESS 2 0.0001
751 ABDOMINAL DISTENSION 13 0.0001
752 THROMBOSIS 10 0.0001
753 MENTAL IMPAIRMENT 3 0.0001
754 HYPOGLYCAEMIA 6 0.0001
755 PNEUMONIA 40 0.0001
756 NEURALGIA 3 0.0001
757 DECUBITUS ULCER 1 0.0001
758 ASPHYXIA 1 0.0001
759 PAIN IN EXTREMITY 36 0.0001
760 LUNG NEOPLASM MALIGNANT 5 0.0001
761 VENTRICULAR TACHYCARDIA 2 0.0001
762 ACUTE CORONARY SYNDROME 1 0.0001
763 FATIGUE 94 0.0001
764 PNEUMONIA ASPIRATION 3 0.0001
765 COAGULOPATHY 2 0.0001
766 FUNGAL INFECTION 4 0.0001
767 URINARY RETENTION 4 0.0001
768 ABDOMINAL PAIN LOWER 3 0.0001
769 FACE OEDEMA 2 0.0001
770 HAEMATEMESIS 3 0.0001
771 HAEMOGLOBIN DECREASED 12 0.0001
772 SCAR 2 0.0001
773 CARDIAC MURMUR 1 0.0001
774 SEPTIC SHOCK 5 0.0001
775 RASH 50 0.0001
776 ARTHRITIS 9 0.0001
777 COLD SWEAT 2 0.0001
778 EAR INFECTION 3 0.0001
779 GOUT 2 0.0001
780 GASTROENTERITIS VIRAL 2 0.0001
781 RASH PRURITIC 6 0.0001
782 PELVIC PAIN 2 0.0001
783 SKIN LESION 3 0.0001
784 RHINORRHOEA 7 0.0001
785 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
786 CONJUNCTIVITIS 2 0.0001
787 AMNESIA 7 0.0001
788 WOUND 3 0.0001
789 APPENDICITIS 1 0.0001
790 DYSARTHRIA 4 0.0001
791 INTESTINAL OBSTRUCTION 4 0.0001
792 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
793 POST PROCEDURAL COMPLICATION 2 0.0001
794 GLAUCOMA 2 0.0001
795 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
796 ERYTHEMA 21 0.0001
797 DYSPEPSIA 10 0.0001
798 BODY TEMPERATURE DECREASED 1 0.0001
799 HEART RATE INCREASED 10 0.0001
800 INJURY 7 0.0001
801 CORONARY ARTERY DISEASE 3 0.0001
802 ASTHENIA 37 0.0001
803 DEATH 84 0.0001
804 THERAPY CESSATION 5 0.0001
805 GYNAECOMASTIA 3 0.0001
806 LIMB DISCOMFORT 3 0.0001
807 PERITONITIS 2 0.0001
808 POLLAKIURIA 4 0.0001
809 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
810 DERMATITIS 2 0.0001
811 CONTUSION 9 0.0001
812 IRRITABLE BOWEL SYNDROME 2 0.0001
813 BREAST CANCER METASTATIC 1 0.0001
814 POOR QUALITY SLEEP 2 0.0001
815 PRURITUS GENERALISED 2 0.0001
816 FAECES DISCOLOURED 2 0.0001
817 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
818 ASPIRATION 1 0.0001
819 BLOOD GLUCOSE FLUCTUATION 1 0.0001
820 LIP SWELLING 3 0.0001
821 STEVENS-JOHNSON SYNDROME 2 0.0001
822 TOOTH DISORDER 2 0.0001
823 NECK PAIN 5 0.0001
824 GLOSSODYNIA 2 0.0001
825 BLISTER 5 0.0001
826 THERAPY NON-RESPONDER 4 0.0001
827 BLOOD CALCIUM DECREASED 1 0.0001
828 SINUSITIS 9 0.0001
829 GASTRIC DISORDER 3 0.0001
830 OROPHARYNGEAL PAIN 8 0.0001
831 RASH MACULAR 3 0.0001
832 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
833 WHEEZING 5 0.0001
834 ATAXIA 1 0.0001
835 PRODUCT PRESCRIBING ERROR 2 0.0001
836 INCORRECT ROUTE OF DRUG ADMINISTRATION 3 0.0001
837 ACCIDENT 1 0.0001
838 ABDOMINAL DISCOMFORT 14 0.0001
839 RENAL IMPAIRMENT 7 0.0001
840 DIABETIC KETOACIDOSIS 2 0.0001
841 CEREBROVASCULAR ACCIDENT 14 0.0001
842 BURSITIS 1 0.0001
843 DISCOMFORT 5 0.0001
844 CYTOPENIA 1 0.0001
845 HEADACHE 51 0.0001
846 INJECTION SITE MASS 3 0.0001
847 MYOCARDIAL INFARCTION 14 0.0001
848 AGEUSIA 2 0.0001
849 HALLUCINATION 6 0.0001
850 BLOOD GLUCOSE INCREASED 15 0.0001
851 HYPOPHAGIA 2 0.0001
852 ADVERSE DRUG REACTION 7 0.0001
853 SEIZURE 9 0.0001
854 ADVERSE EVENT 7 0.0001
855 DISORIENTATION 3 0.0001
856 PANCREATITIS 4 0.0001
857 FALL 25 0.0001
858 SOMNOLENCE 15 0.0001
859 PRODUCT USE ISSUE 14 0.0001
860 DYSKINESIA 3 0.0001
861 DYSPHAGIA 7 0.0001
862 PNEUMONITIS 2 0.0001
863 ACUTE HEPATIC FAILURE 1 0.0001
864 PRURITUS 28 0.0001
865 ABDOMINAL PAIN UPPER 15 0.0001
866 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
867 RESPIRATORY ARREST 2 0.0001
868 ARTHRALGIA 30 0.0001
869 PROCEDURAL PAIN 2 0.0001
870 MEDICATION ERROR 4 0.0001
871 CARPAL TUNNEL SYNDROME 1 0.0001
872 BLOOD TEST ABNORMAL 1 0.0001
873 BLINDNESS UNILATERAL 1 0.0001
874 MUSCLE SPASMS 13 0.0001
875 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
876 PANCREATIC CARCINOMA 2 0.0001
877 GENERAL PHYSICAL HEALTH DETERIORATION 8 0.0001
878 VAGINAL HAEMORRHAGE 3 0.0001
879 DYSPHONIA 4 0.0001
880 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
881 ACUTE MYOCARDIAL INFARCTION 2 0.0001
882 LABORATORY TEST ABNORMAL 2 0.0001
883 PSYCHOTIC DISORDER 2 0.0001
884 BRONCHITIS 5 0.0001
885 RESPIRATORY DISORDER 2 0.0001
886 ANXIETY 19 0.0001
887 TREMOR 11 0.0001
888 TINNITUS 3 0.0001
889 DRUG ADMINISTRATION ERROR 2 0.0001
890 FEMUR FRACTURE 2 0.0001
891 URINARY TRACT INFECTION 11 0.0001
892 ARRHYTHMIA 3 0.0001
893 OCULAR HYPERAEMIA 3 0.0001
894 HEAD INJURY 2 0.0001
895 MOOD SWINGS 2 0.0001
896 BLOOD GLUCOSE DECREASED 3 0.0001
897 MOVEMENT DISORDER 2 0.0001
898 LACTIC ACIDOSIS 2 0.0001
899 ALOPECIA 12 0.0001
900 VISUAL ACUITY REDUCED 2 0.0001
901 MALAISE 26 0.0001
902 CIRCULATORY COLLAPSE 1 0.0001
903 VISION BLURRED 8 0.0001
904 INFLAMMATION 3 0.0001
905 BALANCE DISORDER 5 0.0001
906 HAEMORRHAGE 6 0.0001
907 SPEECH DISORDER 3 0.0001
908 AMENORRHOEA 1 0.0001
909 CEREBRAL HAEMORRHAGE 2 0.0001
910 C-REACTIVE PROTEIN INCREASED 2 0.0001
911 AGRANULOCYTOSIS 1 0.0001
912 INFLUENZA 6 0.0001
913 HEPATIC FUNCTION ABNORMAL 2 0.0001
914 WEIGHT INCREASED 12 0.0001
915 CARDIAC DISORDER 5 0.0001
916 DEPRESSION 12 0.0001
917 BLOOD URINE PRESENT 1 0.0001
918 CONDITION AGGRAVATED 16 0.0001
919 DRY SKIN 7 0.0001
920 ACUTE KIDNEY INJURY 8 0.0001
921 INJECTION SITE PAIN 16 0.0001
922 COVID-19 9 0.0001
923 SURGERY 3 0.0001
924 PARAESTHESIA 8 0.0001
925 CARDIAC FAILURE 4 0.0000
926 NO ADVERSE EVENT 9 0.0000
927 THERAPEUTIC RESPONSE DECREASED 3 0.0000
928 VERTIGO 3 0.0000
929 OSTEOPOROSIS 2 0.0000
930 PRODUCT USE IN UNAPPROVED INDICATION 12 0.0000
931 HYPOAESTHESIA 7 0.0000
932 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
933 PRODUCT DOSE OMISSION 3 0.0000
934 FEELING ABNORMAL 11 0.0000
935 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
936 BLOOD PRESSURE INCREASED 7 0.0000
937 PERIPHERAL SWELLING 7 0.0000
938 APPLICATION SITE PAIN 1 0.0000
939 COLITIS ULCERATIVE 2 0.0000
940 THROAT IRRITATION 2 0.0000
941 SKIN IRRITATION 2 0.0000
942 BLOOD CHOLESTEROL INCREASED 2 0.0000
943 PALPITATIONS 5 0.0000
944 DISEASE RECURRENCE 2 0.0000
945 COMA 2 0.0000
946 MOBILITY DECREASED 3 0.0000
947 JOINT SWELLING 5 0.0000
948 UNDERDOSE 3 0.0000
949 AGITATION 3 0.0000
950 DYSGEUSIA 3 0.0000
951 AGGRESSION 2 0.0000
952 DIABETES MELLITUS 3 0.0000
953 BREAST CANCER FEMALE 1 0.0000
954 DRUG EFFECT DECREASED 2 0.0000
955 DRY MOUTH 3 0.0000
956 ABNORMAL DREAMS 1 0.0000
957 TREATMENT FAILURE 3 0.0000
958 TOXICITY TO VARIOUS AGENTS 6 0.0000
959 SKIN EXFOLIATION 3 0.0000
960 FLATULENCE 2 0.0000
961 HERPES ZOSTER 2 0.0000
962 CATARACT 2 0.0000
963 GASTROINTESTINAL DISORDER 3 0.0000
964 IRRITABILITY 2 0.0000
965 VISUAL IMPAIRMENT 4 0.0000
966 EXPOSURE DURING PREGNANCY 2 0.0000
967 BONE DENSITY DECREASED 1 0.0000
968 DRUG INTERACTION 5 0.0000
969 MIGRAINE 3 0.0000
970 DRUG INTOLERANCE 3 0.0000
971 INSOMNIA 8 0.0000
972 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
973 HEPATIC ENZYME INCREASED 2 0.0000
974 ILLNESS 3 0.0000
975 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
976 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
977 NASOPHARYNGITIS 5 0.0000
978 ACNE 2 0.0000
979 INJECTION SITE BRUISING 2 0.0000
980 ABORTION SPONTANEOUS 1 0.0000
981 EMOTIONAL DISTRESS 3 0.0000
982 DRUG DOSE OMISSION 4 0.0000
983 PRODUCT STORAGE ERROR 2 0.0000
984 DEVICE ISSUE 2 0.0000
985 COGNITIVE DISORDER 1 0.0000
986 GAIT DISTURBANCE 4 0.0000
987 PRODUCT DOSE OMISSION ISSUE 6 0.0000
988 ARTHROPATHY 1 0.0000
989 DRUG INEFFECTIVE 21 0.0000
990 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
991 ASTHMA 1 0.0000
992 INCORRECT DOSE ADMINISTERED 2 0.0000